Tvardi Therapeutics, Inc. (TVRD) earnings
Quarterly and annual TVRD reports and results, each read against the price at its own news timestamp. Back to the TVRD overview →
8 measured TVRD earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Tvardi Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +4.97% | +4.97% | |
| Tvardi Therapeutics Announces Second Quarter 2026 Results and Provides Business Update | Press release | +4.97% | +4.97% | |
| Form 10-Q Tvardi Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -3.06% | -1.65% | |
| Tvardi Therapeutics Announces First Quarter 2026 Results and Provides Business Update | Press release | -3.06% | -1.65% | |
| Form 10-K Tvardi Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -3.45% | -4.15% | |
| Form 10-Q Tvardi Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -2.40% | |
| Tvardi Therapeutics Announces Second Quarter 2025 Results and Provides Business Update | Press release | +0.00% | -2.40% | |
| Tvardi Therapeutics Announces First Quarter 2025 Results and Provides Business Update | Press release | +0.00% | +3.86% |
Keep exploring
More TVRD: analyst actions → · SEC filings → · TVRD overview →